JAMA Editors' Summary COVID-19 Vaccine and Pregnancy Outcomes, Valacyclovir for Alzheimer Disease, Abortion Access in Los Angeles, and more
12 snips
Dec 19, 2025 Discover how COVID-19 vaccination can significantly lower risks of severe maternal outcomes and preterm births. Learn about the disappointing findings of a study on valacyclovir for Alzheimer's, indicating it doesn't curb cognitive decline. Explore the alarming survey revealing limited abortion access in California clinics. Hear insights on the impact of potential policy changes to school vaccine mandates. Plus, get updates on a new H3N2 flu variant and WHO obesity medication guidelines. Dive into critical health discussions with expert perspectives!
AI Snips
Chapters
Transcript
Episode notes
Vaccine Lowers Pregnancy Risks
- COVID-19 vaccination during pregnancy was associated with lower risk of severe maternal infection and preterm birth.
- The association held across time periods and circulating SARS-CoV-2 variants.
Antiviral Did Not Slow Alzheimer's
- Valacyclovir did not reduce cognitive decline in early symptomatic Alzheimer's disease with HSV seropositivity.
- Authors conclude valacyclovir should not be recommended for this indication.
Viral Hypothesis Remains Unsettled
- The trial refutes valacyclovir's therapeutic role in symptomatic Alzheimer's related impairment.
- The editorial highlights ongoing debate about viral roles in Alzheimer's risk and manifestation.
